Direxion Daily Healthcare Bull 3x Shares (CURE)
| Assets | $177.82M |
| Expense Ratio | 0.99% |
| PE Ratio | 23.73 |
| Shares Out | n/a |
| Dividend (ttm) | $2.05 |
| Dividend Yield | 2.02% |
| Ex-Dividend Date | Dec 21, 2023 |
| Payout Ratio | 47.84% |
| 1-Year Return | -12.44% |
| Volume | 27,116 |
| Open | 101.69 |
| Previous Close | 101.44 |
| Day's Range | 100.62 - 102.07 |
| 52-Week Low | 75.39 |
| 52-Week High | 116.38 |
| Beta | n/a |
| Holdings | 70 |
| Inception Date | Jun 15, 2011 |
About CURE
Fund Home PageThe Direxion Daily Healthcare Bull 3x Shares (CURE) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies. CURE was launched on Jun 15, 2011 and is issued by Direxion.
Top 10 Holdings
290.89% of assets| Name | Symbol | Weight |
|---|---|---|
| HEALTH CARE SELECT SECTOR INDEX SWAP | n/a | 118.04% |
| HEALTH CARE SELECT SECTOR INDEX SWAP | n/a | 75.74% |
| HEALTH CARE SELECT SECTOR INDEX SWAP | n/a | 39.30% |
| DREYFUS GOVT CASH MAN INS | n/a | 21.85% |
| GOLDMAN FINL SQ TRSRY INST 506 | n/a | 11.12% |
| UnitedHealth Group Incorporated | UNH | 6.43% |
| Eli Lilly and Company | LLY | 6.14% |
| Johnson & Johnson | JNJ | 4.99% |
| Merck & Co., Inc. | MRK | 3.65% |
| AbbVie Inc. | ABBV | 3.62% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 21, 2023 | $0.57266 | Dec 29, 2023 |
| Sep 19, 2023 | $0.45383 | Sep 26, 2023 |
| Jun 21, 2023 | $0.53725 | Jun 28, 2023 |
| Mar 21, 2023 | $0.48743 | Mar 28, 2023 |
| Dec 20, 2022 | $0.14407 | Dec 28, 2022 |
| Sep 20, 2022 | $0.18422 | Sep 27, 2022 |
News
AI Adoption in Healthcare Spells Opportunity in 2 ETFs
Traders eyeing potential plays in the new year may want to look at the healthcare sector given its growing adoption of artificial intelligence (AI). Technological advancement in healthcare should spel...
Top Performing Leveraged/Inverse ETFs: 07/23/2023
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Healthcare Could Be Showing Signs of a Bullish Summer
Investors often view healthcare as a safe haven sector, but as market confidence returns, demand for riskier assets could push investors away. However, there could be signs of early summer bullishness...
3 Triple Leveraged ETFs Traders Can Consider in 2023
The default play for traders in 2023 may be to simply bet on sectors that were hit the hardest in 2022 and hope for a dead cat bounce. However, in a market still full of unknowns, some precaution is n...
Rising Healthcare Costs Put This Leveraged ETF Into Perspective
Inflation hasn't been the only thing going up as of late. Rising healthcare costs have also been hitting consumers, putting the Direxion Daily Healthcare Bull 3X ETF (CURE) in perspective for traders ...
Despite Recent Weakness, Fundamentals Still Strong for Healthcare
Equities across the board haven't been safe from the downward sell-off pressure. That also goes for healthcare, which is typically steady in times of volatility.
Amid Monkeypox Outbreak, This 3X Leveraged ETF Provides Exposure To Health Sector: What To Watch
The Direxion Daily Healthcare Bull 3X Shares (NYSE: CURE) gapped up almost 2.52% higher on Monday in response to outbreaks of monkeypox being reported in several western nations. CURE is a triple leve...
Latest Bills on Capitol Hill Tee Up Trades in These Two ETFs
The House of Representatives approved the trillion-dollar infrastructure bill last Friday night, opening up opportunities for a pair of ETF trades from Direxion Investments. The obvious play is to get...
Tailwinds Are Blowing Behind Healthcare and the “CURE” ETF
Innovation-driven by rising demands on the healthcare system can create a strong growth environment for traders using the Direxion Daily Healthcare Bull 3X ETF (CURE). The rising population and improv...
3 ETFs to Access a Changing Pharmaceutical Industry
A changing pharmaceutical industry is setting up a few trades in the leveraged fund space, specifically for ETFs from Direxion Investments. One of the catalysts for change, especially within the past ...
Extra Bullish on Healthcare? Consider Leverage, the CURE ETF
The healthcare sector has always been seen as a safe investment, but given the way the pandemic has affected the industry, there may remain dynamic trading opportunities with the Direxion Daily Health...
Biden's Infrastructure Can Put These 2 Leveraged Funds in Play
U.S. president Joe Biden's infrastructure plan is opening up ETF trading possibilities from multiple angles. One way is playing its healthcare component via funds like the Direxion Daily Healthcare Bu...
Direxion Leveraged Healthcare ETF Ready To Make House Calls In 2021
Coronavirus vaccines are being distributed, but case counts continue rising, a pair of scenarios ensuring the healthcare center will again be an epicenter of activity in 2021. What Happened Healthcare...
Healthcare Sector Is Gonna Get Exciting, Capture That With CURE
The healthcare sector is shaking off rust accrued earlier this year and with the 2020 election season mostly behind the group – pending next month's Georgia Senate runoff elections – market observers ...
A Vaccine Is Coming. So What?
For the better part of 2020, the market has been ruled less by hard numbers and more by speculation about what the hard numbers may look like once the pandemic is “over” and things get back to “normal...
A CURE For The Common Earnings Play
It has the potential to be lost in this week's earnings hubbub, which is dominated by growth-ier communication services and technology stocks, but don't sleep on reports from blue-chip healthcare stoc...
Healthcare ETFs Are Hot Right Now, but Not All Are Created Equal
The coronavirus pandemic put healthcare exchange-traded funds (ETFs) in the forefront as medical providers are an essential component in the global market landscape. However, investors shouldn’t suck ...
3 Leveraged Healthcare ETFs Soaring This Month
The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidem...
Jablonski: Biotech presents a good buying opportunity
Sylvia Jablonski of Direxion discusses why biotech stocks and ETFs are attractive right now, due to their cheapness relative to the rest of the market.
It's Time To Consider Leveraged Healthcare ETFs
For traders using leveraged sector exchange-traded funds, one key to successfully using these products in the short-term fashion in which they are intended is to treat leveraged ETFs as event-driven t...